The India Genomics Market reached a size of USD 2.2 Billion in 2024 and is anticipated to grow to USD 9.0 Billion by 2033. The market is projected to expand at a CAGR of 16.10% during the forecast period from 2025 to 2033. Growth is driven by the emergence of personalized or precision medicine, which tailors treatments based on an individual's genetic makeup. The report presents a thorough review featuring the India Genomics Market Size, share, trends, and research of the industry.
STUDY ASSUMPTION YEARS
- Base Year: 2024
- Historical Year/Period: 2019-2024
- Forecast Year/Period: 2025-2033
INDIA GENOMICS MARKET KEY TAKEAWAYS
- Current Market Size: USD 2.2 Billion in 2024
- CAGR: 16.10% during 2025-2033
- Forecast Period: 2025-2033
- The market is propelled by the rise in chronic diseases and the demand for genomic solutions.
- Declining costs of DNA sequencing have increased accessibility and adoption.
- Collaborative efforts among research institutions, pharma companies, and healthcare providers accelerate market growth.
- Personalized medicine awareness boosts demand for genomic technologies.
- Technological progress in bioinformatics and data analytics enhances clinical relevance of genomics.
Sample Request Link: https://www.imarcgroup.com/india-genomics-market/requestsample
MARKET TRENDS
The genomics market in India is witnessing unprecedented growth propelled largely by the rising prevalence of chronic diseases, which significantly increases demand for advanced genomic solutions to understand the genetic basis of these disorders. Furthermore, the cost of DNA sequencing technologies is decreasing sharply, enabling a wider segment of the population and institutions to adopt genomics extensively.
Collaborative initiatives among research institutions, pharmaceutical firms, and healthcare providers have created a synergistic research environment, accelerating genomic research and product development. This cooperation fuels the market's expansion by fostering innovative diagnostics and therapeutic solutions.
Growing awareness about personalized medicine, which customizes treatments based on genetic profiles, is a potent trend elevating genomics demand. Concurrently, advances in bioinformatics and data analytics improve the interpretation and clinical application of genomic information, enhancing the utility and acceptance of these technologies in healthcare.
MARKET GROWTH FACTORS
The growth of the Indian genomics market is primarily driven by multiple factors. First, the surge in chronic diseases, such as cancer and genetic disorders, necessitates genetic testing and genomic solutions, pushing market demand upward. Secondly, government initiatives and funding in biotechnology and genomics research have boosted sector growth by facilitating infrastructure and collaborations.
Another key driver is the decreasing cost of DNA sequencing technologies, making genomic testing and research more affordable and accessible, thus broadening the market reach. Additionally, expanding clinical applications, including oncology, rare diseases, and ancestry tracking, contribute to growing adoption of genomic technologies across healthcare domains.
Furthermore, the increasing number of research collaborations among academic, industrial, and healthcare entities in India fosters development and commercialization of genomics solutions. Combined with rising healthcare awareness among the population about genetic testing and personalized medicine, these factors collectively drive the genomics market expansion in India.
Get Your Customized Market Report Here
MARKET SEGMENTATION
Component Insights:
- Products
- Instruments and Software
- Consumables and Reagents
- Services
- Core Genomics Services
- NGS-Based Services
- Biomarker Translation Services
- Computational Services
- Others
Description: The market includes products like instruments, software, consumables, and reagents, alongside various services including core genomics, next-generation sequencing (NGS), biomarker translation, computational analyses, and other specialized services.
Application Insights:
- Functional Genomics
- Epigenomics
- Biomarkers Discovery
- Pathway Analysis
- Others
Description: The application spectrum covers functional genomics to understand gene functions, epigenomics studying gene expression regulation, biomarker discovery for diagnostics, pathway analysis, and additional applications.
Technology Insights:
- Sequencing
- Microarray
- Polymerase Chain Reaction
- Nucleic Acid Extraction and Purification
- Others
Description: Technologies used include sequencing methods, microarray platforms, PCR for DNA amplification, nucleic acid extraction and purification techniques, among others.
End User Insights:
- Research Centers
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Others
Description: The market serves diverse end users such as academic and private research centers, healthcare hospitals and clinics, pharma and biotech companies, plus other users.
Regional Insights:
- North India
- West and Central India
- South India
- East and Northeast India
Description: The geographic segmentation tracks major Indian regions including North India, West and Central India, South India, and East and Northeast India.
REGIONAL INSIGHTS
The report does not explicitly identify a dominant region by market share or CAGR. It segments the market by North India, West and Central India, South India, and East and Northeast India but specific statistics such as market shares or growth rates per region are not provided in the source.
In summary, regional India genomics markets are covered comprehensively; however, quantitative regional dominance data is not provided in the source text.
CUSTOMIZATION NOTE:
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
ABOUT US
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
CONTACT US
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: [email protected],
Tel No: (D) +91-120-433-0800,
United States: +1-201-971-6302
